Atossa Therapeutics Inc (ATOS)

Mar 03, 2026

Cash from financing activities of Atossa Therapeutics, Inc. – MUN:YAG - TradingView

Mar 03, 2026

Mar 03, 2026

Free cash flow of Atossa Therapeutics, Inc. – MUN:YAG - TradingView

Mar 03, 2026

Mar 03, 2026

Aug Fed Impact: Is Atossa Therapeutics Inc stock undervalued right nowQuarterly Profit Summary & Daily Growth Stock Investment Tips - baoquankhu1.vn

Mar 03, 2026

Mar 03, 2026

Total liabilities & shareholders' equities of Atossa Therapeutics, Inc. – MUN:YAG - TradingView

Mar 03, 2026

Mar 03, 2026

Atossa Therapeutics advances Z-endoxifen platform in oncology and DMD targeting molecular precision - Traders Union

Mar 03, 2026

Feb 28, 2026

ATOS PE Ratio & Valuation, Is ATOS Overvalued - Intellectia AI

Feb 28, 2026

Feb 26, 2026

Is Atossa Therapeutics Inc. stock influenced by commodity pricesJuly 2025 Recap & Daily Profit Focused Screening - mfd.ru

Feb 26, 2026

Feb 26, 2026

ATOS Should I Buy - Intellectia AI

Feb 26, 2026

Feb 24, 2026

ETF Watch: Is Chatham Lodging Trust a turnaround story2025 Market Trends & Weekly Chart Analysis and Guides - baoquankhu1.vn

Feb 24, 2026

Feb 24, 2026

ATOS Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan

Feb 24, 2026

Feb 23, 2026

Atossa Therapeutics outlines Z-Endoxifen strategy for breast cancer prevention - Traders Union

Feb 23, 2026

Feb 21, 2026

Atossa Therapeutics Launches New $50 Million ATM Program - The Globe and Mail

Feb 21, 2026

Feb 20, 2026

Atos (ATOS) cuts $100M Jefferies ATM to $0, effective Feb 20, 2026 - Stock Titan

Feb 20, 2026

Feb 20, 2026

Atossa Therapeutics (NASDAQ: ATOS) launches $50M at-the-market stock offering - Stock Titan

Feb 20, 2026

Feb 20, 2026

Atossa Genetics Inc. (NASDAQ:ATOS) Receives $95.00 Consensus PT from Analysts - Defense World

Feb 20, 2026

Feb 18, 2026

Atossa Therapeutics Regains Nasdaq Compliance, Avoids Delisting Risk - The Globe and Mail

Feb 18, 2026

Feb 18, 2026

Net debt of Atossa Therapeutics, Inc. – MUN:YAG - TradingView

Feb 18, 2026

Feb 17, 2026

Patterns Watch: What is Atossa Therapeutics Incs TAM Total Addressable Market2025 Breakouts & Breakdowns & High Accuracy Trade Signal Alerts - baoquankhu1.vn

Feb 17, 2026

Feb 17, 2026

Atossa Therapeutics, Inc. Balance Sheet – MUN:YAG - TradingView

Feb 17, 2026

Feb 17, 2026

Atossa Therapeutics Disclosed Failure to Satisfy a Continued Listing Rule or Standard - TradingView

Feb 17, 2026

Feb 17, 2026

Atossa Therapeutics to Participate in UCSF women health event - Traders Union

Feb 17, 2026

Feb 17, 2026

Basic earnings per share (basic EPS) of Atossa Therapeutics, Inc. – MUN:YAG - TradingView

Feb 17, 2026

Feb 16, 2026

Atossa Therapeutics: Key Developments and Upcoming Catalysts - AD HOC NEWS

Feb 16, 2026

Feb 16, 2026

Atossa Genetics Inc. (NASDAQ:ATOS) Short Interest Up 29.7% in January - Defense World

Feb 16, 2026

Feb 15, 2026

Is Atossa Therapeutics Inc. likely to announce a buybackJuly 2025 Rallies & Weekly Breakout Watchlists - mfd.ru

Feb 15, 2026

Feb 13, 2026

Is Atossa Therapeutics Inc. a speculative investmentWeekly Market Report & Free Technical Pattern Based Buy Signals - mfd.ru

Feb 13, 2026

Feb 12, 2026

Jobs Data: Is Atossa Therapeutics Incs growth already priced inJuly 2025 Price Swings & Stepwise Swing Trade Plans - baoquankhu1.vn

Feb 12, 2026

Feb 11, 2026

Atossa Therapeutics Issues Letter to Shareholders Highlighting 2025 Accomplishments and 2026 Outlook - The Malaysian Reserve

Feb 11, 2026

Feb 11, 2026

Atossa Therapeutics issues letter to shareholders highlighting 2025 accomplishments and 2026 outlook - marketscreener.com

Feb 11, 2026

Feb 11, 2026

Atossa Therapeutics Issues 2026 Outlook and Strategic Update - TipRanks

Feb 11, 2026

Feb 11, 2026

Atossa Therapeutics Issues Letter To Shareholders Highlighting 2025 Accomplishments And 2026 Outlook - TradingView

Feb 11, 2026

Feb 11, 2026

Atossa Therapeutics Issues 2026 Shareholder Letter Highlighting Key Developments - TradingView

Feb 11, 2026

Feb 11, 2026

Can Atossa Therapeutics Inc. be recession proofJuly 2025 Momentum & Community Consensus Trade Signals - mfd.ru

Feb 11, 2026

Feb 10, 2026

Atossa Therapeutics launches research program for oral therapy in DMD - Traders Union

Feb 10, 2026

Feb 09, 2026

We Think Atossa Therapeutics (NASDAQ:ATOS) Needs To Drive Business Growth Carefully - Yahoo Finance

Feb 09, 2026

Feb 09, 2026

Market Outlook: Is Atossa Therapeutics Inc part of any ETFWeekly Trading Summary & Weekly Momentum Picks - baoquankhu1.vn

Feb 09, 2026

Feb 07, 2026

Cash from financing activities of Atossa Therapeutics, Inc. – GETTEX:YAG - TradingView

Feb 07, 2026

Feb 07, 2026

Cost of goods sold of Atossa Therapeutics, Inc. – GETTEX:YAG - TradingView

Feb 07, 2026

Feb 05, 2026

Mammoth Energy sets March 6 call to review full-year 2025 results - Stock Titan

Feb 05, 2026

Feb 05, 2026

Atossa Therapeutics Maintains Strong Market Position for (Z)-End - GuruFocus

Feb 05, 2026

Feb 05, 2026

Atossa Therapeutics Maintains Strong Market Position for (Z)-Endoxifen for Duchenne Muscular Dystrophy as Congress Reauthorizes Priority Review Voucher Program - Sahm

Feb 05, 2026

Feb 04, 2026

ATOS stock tumbles 32% — here’s what retail investors think of the reverse stock split - MSN

Feb 04, 2026

Feb 03, 2026

Atossa Genetics (NASDAQ:ATOS) Sees Large Volume IncreaseWhat's Next? - MarketBeat

Feb 03, 2026

Feb 03, 2026

Atossa Therapeutics Inc Share Price USD0.18 - Hargreaves Lansdown

Feb 03, 2026

Feb 02, 2026

ATOS Stock Tumbles 32% — Here’s What Retail Investors Think Of The Reverse Stock Split - Asianet Newsable

Feb 02, 2026

Feb 02, 2026

Atossa Genetics (NASDAQ:ATOS) Sets New 1-Year LowWhat's Next? - MarketBeat

Feb 02, 2026

Feb 02, 2026

Atossa Therapeutics (ATOS) enters reverse-split Monday as Nasdaq compliance clock tightens - TechStock²

Feb 02, 2026

Jan 31, 2026

Atossa Genetics Inc. (NASDAQ:ATOS) Short Interest Up 56.4% in January - MarketBeat

Jan 31, 2026

Jan 30, 2026

Aug PreEarnings: How volatile is SKYQ stockWeekly Market Summary & Weekly Market Pulse Updates - baoquankhu1.vn

Jan 30, 2026

Jan 29, 2026

Atossa Genetics (NASDAQ:ATOS) Shares Set to Reverse Split on Monday, February 2nd - MarketBeat

Jan 29, 2026

Jan 28, 2026

Can Atossa Therapeutics Inc. lead its sector in growthGap Up & Verified Swing Trading Watchlist - mfd.ru

Jan 28, 2026

Jan 27, 2026

Atossa Therapeutics, Inc.'s (NASDAQ:ATOS) Profit Outlook - simplywall.st

Jan 27, 2026

Jan 26, 2026

Risk Hedge: Can Adagene Inc. Depositary Receipt stock outperform in a bear market2025 Sector Review & Long-Term Safe Investment Plans - baoquankhu1.vn

Jan 26, 2026